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Abstract
Hypertension is a common chronic disease affecting nearly one-third of the United States
population. Many interventions have been designed to help patients manage their hypertension.
With the evolving climate of healthcare, rapidly developing technology, and emphasis on
delivering patient-centered care, home-based blood pressure telemonitoring is a promising tool to
help patients achieve optimal blood pressure (BP) control. Home-based blood pressure
telemonitoring is associated with reductions in blood pressure values and increased patient
satisfaction. However, additional research is needed to understand cost-effectiveness and long-
term clinical outcomes of home-based BP monitoring. We review key interventional trials
involving home based BP monitoring, with special emphasis placed on studies involving
additionally behavioral modification and/or medication management. Furthermore, we discuss the
role of home-based blood pressure telemonitoring within the context of the patient-centered
medical home and the evolving role of technology.
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Hypertension is a chronic condition, affecting nearly one-third of American men and women
[1]. Despite being the focus of much public health and a myriad of interventions
implemented to promote improved patient self-management and hypertension control, the
hypertension prevalence rate has remained stable for over a decade [2]. Though the
prevalence of hypertension remains high, some interventions have proven successful at
helping patients with self-management.
Central to many successful interventions is home-based telemonitoring where a blood
pressure (BP) monitor is placed in a patient’s home. In home-based telemonitoring, patients
self-monitor their own vitals, such as BP and pulse rate, and communicate values to a
healthcare provider or clinic either in person, with a self-kept log, or remotely via telephone
or e-Health-related technology. It is estimated that half of hypertensive patients’ households
in the United States have a home-monitoring BP device for their general use [3].
As a mechanism to improve disease control and conserve resource utilization, home-based
BP monitoring has become an increasingly attractive mechanism for chronic disease
management. Relative to clinic-based BP monitoring, home-based monitoring may
encourage more appropriate resource utilization by curtailing the need for unnecessary in-
person clinic visits (e.g., visits solely for a BP check), while simultaneously initiating
needed visits when a patient’s BP is out of target range. Home-based monitoring may
accelerate the speed at which a patient achieves their target BP goals. Patients can alter their
health behaviors or have adjustments made in their medication regimen between visits,
avoiding the need to wait months between visits for adjustments. Home-based monitoring
may also alert the provider of new changes in a patient’s health that may manifest with
uncontrolled BP.
The use of home BP monitoring is consistent with the Patient Centered Medical Home
(PCMH), a healthcare model that facilitates partnerships between patients, their providers,
involving family members and ancillary clinical staff as appropriate [4–6]. In addition to
traditional face-to-face clinic visits, the PCMH emphasizes patient-centered care that
involves providing care outside the clinic as well, which has been linked to improve patient
satisfaction and care provided in innovative ways [5, 7]. This link with improved patient
satisfaction may also be true of home-based care; in addition to informing a supplementary
measure of BP control, home-based telemonitoring may be preferred by patients. Telephone
contact offers a medium enabling patients to be reached regardless of geographic location
and has been shown effective in changing multiple patient behaviors [8–10]. Perhaps
resulting from decreased transportation burden and time savings, home-based monitoring
may be more convenient for patients[11] and may build feelings of control and support for
chronic disease self-management [12]. This is in keeping with the tenets of the PCMH [5].
The economic case supporting home-based BP monitoring is mixed. Several studies have
demonstrated that home-based BP monitoring, especially when coupled with behavioral
interventions, may be cost-additive or cost-neutral to the healthcare system in the short-term
[13–17]. It is generally posited that the initial expense will result in longer-term savings
through cardiovascular disease reduction. However, this has not been well studied. One
issue leading to the inadequacy of evidence regarding cost implications is the vast variability
in terms of equipment price. A simple home BP monitor costs approximately $40, while a
BP monitor appropriate for telemonitoring usually costs about ten times that amount.
Home-based BP monitoring also provides a potentially better prognostic indicator of
cardiovascular mortality than clinic-based monitoring [18]. BP varies daily depending on an
individual’s physiological state and situational factors; the harmful effects of hypertension
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are presumed to be due to prolonged, elevated average BP [19, 20], accurate and
longitudinal measurements are needed. There are many issues inherent to the accuracy of BP
measurements ranging from “white coat syndrome” where a patient’s BP values are
artificially elevated due to anxiety over interaction with healthcare professionals – to
inaccurate values obtained resulting from poor procedures in the clinic such as allowing
insufficient resting times prior to obtaining clinic BP values. Similarly, the accuracy of
home-based BP readings may also vary due to variation in method. A recent secondary
analysis of a large, randomized, clinical trial compared strategies for home- or clinic-based
BP monitoring to determine the optimal methodology for obtaining clinically meaningful BP
measurements [21]. In the underlying trial, participants were asked to record BP values
every other day at the same time. A minimum of three values over two weeks was required
and only values spaced over 12 hours were included. Participants with values greater than
one standard deviation above the norm were excluded. The study concluded that the best
approach for correctly classifying BP control should be an average of several BP
measurements including both measurements from the clinical and home-based settings [21].
This paper was commissioned for Current Hypertension Reports to discuss the role of home
BP telemonitoring in managing adults with hypertension. We reviewed key papers
describing interventional trials, with special emphasis placed on studies that included home
BP monitoring and involved behavioral modification and/or medication management.
Because there are numerous publications describing home-based BP monitoring [10, 22–
30], this will not be a comprehensive literature review. Rather, this paper will highlight
rigorously designed trials, expressly those published within the previous three years (e.g.,
2010–2012). To identify manuscripts we searched Medline via PubMed using the following
selected MeSH terms: hypertension, ambulatory blood pressure monitoring, and telephone.
Articles were limited to those in the English language, published from January 1, 2009
through October 1, 2012. Reviews and meta-analyses were excluded. We present a summary
of findings from recent trials including a description of study design, the role of the
interventionist, and specific methodological approaches. Specific methodological
approaches include factors such as variation in frequency of home-based monitoring;
transmitting that information; and when, how, and who intervenes with patients. We also
make recommendations about future directions for home-based BP telemonitoring research
and interventions.
The Professional Role of the Interventionist
Patient-centered hypertension management requires a team-oriented approach often
involving multidisciplinary roles [31]. The professional role of the interventionist impacts
the content and delivery of a hypertension management program. In recent trials, nurses with
varying levels of training [10, 23, 24, 27, 32], and clinical pharmacists [28, 29] have each
taken on this role with merits to each of these interventionist choices.
Across multiple chronic diseases, nurse-delivered interventions have demonstrated improved
patient outcomes [10, 23, 27, 33, 34]. Nurses’ training makes them particularly well suited
to provide patient education and behavioral counseling, areas that are critical to
interventions for many chronic diseases. Depending on the complexity of the program,
appropriate nurse interventionists include licensed practical nurses (LPN), registered nurses
(RN) and advanced nurse practitioners (NP). These nursing professionals are trained to
address lifestyle and behavioral actions such as diet and exercise patterns, strategies for
weight reduction, and smoking cessation, among others. Nurses at all practice levels are
equipped to educate patients on proper home-based BP monitoring techniques, procedures
for telemonitoring, and interpretation about appropriate BP thresholds. LPNs and RNs are
typically not allowed to initiate, discontinue or modify pharmacotherapy. When there is a
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clinical indication requiring medication adjustments, the majority of nurses (i.e., LPNs and
RNs) are reliant on involvement from a physician, pharmacist, or mid-level practitioner
While optimal hypertension management requires lifestyle change, for many patients the
medication management is the cornerstone of BP control. This necessitates an
interventionist with an in depth understanding of both behavioral and pharmacotherapy and
an advanced scope of practice to provide medication management when indicated. These
interventionists include Nurse Practitioners and Clinical Pharmacists.
Nurse practitioners (NP) are advanced practice registered nurses with additional training
enabling them to prescribe or manage pharmacotherapy. Like LPNs and RNs, Nurse
Practitioners (NPs) are trained to provide preventive care and to engage patients in self-care.
Because nursing scopes of practice are state-regulated, care provided by NPs varies widely.
In certain institutions, such as the Veteran Affairs (VA) healthcare system, NPs follow
federal guidelines enabling more autonomy. NPs diagnose and manage acute and chronic
conditions while emphasizing health promotion and disease prevention. Their services
involve ordering, conducting, and interpreting diagnostic and laboratory tests; prescribing
pharmacologic agents and non-pharmacologic therapy; and teaching and counseling.
Clinical pharmacists have obtained a doctoral degree in pharmacy and typically complete
post-graduate residency and/or fellowship training, making them experts in the therapeutic
use and monitoring of medications [35]. They are source of counsel regarding safe,
appropriate, and cost-effective medication use [36, 37]. Like NP with additional training and
scopes of practice, Clinical Pharmacists are able to prescribe and manage pharmacotherapy.
Clinical pharmacists are source of counsel regarding safe, appropriate, and cost-effective
medications use [36, 37]. State regulations dictate whether pharmacists can practice
independently or collaboratively with physicians. Operating under a defined scope of
practice, pharmacists may initiate, discontinue, or adjust pharmacotherapy based on clinical
indications [29, 35–37]. Complementing other health disciplines, clinical pharmacists are
equipped to address medication-related issues such as providing patient education, managing
side effects, and improving non-adherence. Clinical pharmacist-administered behavioral and
medication management interventions have been shown to improve blood pressure control
and the management of other chronic conditions including reducing cardiovascular risk [35].
To date though, most of the evidence supporting pharmacist-driven interventions has been
provided in a traditional community-based setting rather than through telemonitoring [38–
43]. As a result of the unique expertise and capabilities of differing professions, the
intervention content may be guided by the interventionist’s professional role. Successful
interventions are designed with alignment between the professional role of the
interventionist, targeted health behaviors, intervention content, and outcome goal.
Notwithstanding, though a NP or pharmacist may be appear to be ideal interventionist with
their pharmacotherapy privileges, cost-effectiveness is a major factor as LPNs and RNs may
require significantly less monetary resources.
A central tenet in the PCMH construct is the use of care teams. This means involving a
multidisciplinary team of professionals – encompassing nurses, pharmacists, physicians, and
others – with the patient at the core. This team structure enables healthcare professionals to
leverage their specific skillset to the fullest. For example, pharmacists may facilitate
medication adherence, while also providing other lifestyle self-management programs and
provide medication adjustments.
Behavioral Modification +/− Medication Management
A number of randomized controlled trials (RCTs) have been conducted involving elements
of home-based BP telemonitoring. Studies vary extensively in terms of content frequency of
Zullig et al. Page 4













self-monitoring, frequency of reporting home-monitored values, clinicians’ involvement,
duration, and setting. Most commonly, interventions for home-based BP telemonitoring
include an educational component, behavioral modification, and/or medication management.
Trials involving a behavioral component, either alone or in tandem with medication
management, have been deemed the most effective [44]. A principle difference is whether
interventions use behavioral modification alone, or behavioral modification coupled with
medication management. We highlight key studies using each of these approaches.
Behavioral Modification Alone—Hebert and colleagues designed a study to address BP
control using behavioral modification alone among 416 minority patients at one community
clinic and four hospital-based outpatient clinics in Harlem, New York [24]. A RN
interventionist provided face-to-face counseling with patients, focused on home-based BP
telemonitoring, BP diaries, nutritional education, and strategies to improve medication
adherence. Participants were African American or Hispanic patients with a history of
uncontrolled hypertension receiving care at one large private academic medical center, two
medium-size municipal hospitals, or one private community hospital. The intervention
persisted for nine months with “periodic” telephone-based contacts and a follow-up BP
measurement at 18 months. Patients were randomized to one of three arms: 1) usual care; 2)
home BP monitoring plus one in-person counseling session and nine months of telephone
follow-up; or 3) home BP monitoring alone. Overall, the study found that home BP
monitoring alone was no more effective than usual care. However, when home BP
monitoring occurred in tandem with nurse-administered telemonitoring, there was an 8.2-
mmHg reduction in systolic BP at the end of the intervention in the nurse group over usual
care. The improvement dissipated by the 18-month follow-up measurement [24]. However,
there was not data on the cost of the program.
Similarly, Bosworth et al conducted a RCT at two university-affiliated primary care clinics
in Durham, North Carolina [22]. The study randomized 636 patients with hypertension, not
necessarily out of control at baseline to receive either: 1) usual care; 2) bi-monthly tailored
nurse-administered telephone intervention targeting hypertension-related behaviors; 3) BP
monitoring with 3 BP recordings weekly; 4) or a combination of the two interventions. A
board certified registered nurse administered the intervention. Compared to the usual care
group, at 12 months the mean systolic BP was 1.6 mmHg lower in the behavioral group, 3.7
mmHg lower in the home BP monitor group, and 3.3 mmHg lower in the combined group.
By 24 months the improvements persisted only in the combined group relative to the usual
care group. Relative to usual care, the adjusted 24 month difference −3.9 mmHg among
patients in the combined intervention. Findings were similar for diastolic BP changes over
time. The authors concluded that this signifies the synergistic effect of the home monitoring
and behavioral interventions on improving BP over time [22]. The authors reported that the
interventions are cost-additive to the health-care system in the short term. Intervention costs
were estimated at $90 (S.D, $2) for home blood pressure monitoring, $345 (S.D., $64) for
the behavioral intervention ($31 per telephone encounter), and $416 (S.D., $93) for the
combined intervention.
In a European study, Kerry and colleagues recruited 381 participants from stroke clinics
[26]. Participants were first visited in their homes and then randomly assigned to receive
either usual care or home-based monitoring. Participants in the home-based monitoring
group were given a blood pressure monitor, trained on its use, and provided with nurse-
administered telephone support. While the intervention group had better control than the
usual care group, the difference was not statistically significant. The mean difference in
systolic reduction between the groups was 0.3-mmHg at 12 months. Though this subtle
change may not be clinically meaningful, it suggests that short-term improvements in BP
control can be achieved with behavioral modification alone [26].
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These studies suggest that behavioral modification, unaccompanied by medication
management, can be effective in controlling BP. However, patient interaction with an
interventionist is critical for success. This interaction provides the underpinning for
behavioral modification and informs medication management, both of which are critical
elements in effective BP control.
Behavioral Modification + Medication Management—Many home-based
telemonitoring interventions supplement behavioral modification with medication
management to promote BP control. The Hypertension Intervention Nurse Telemedicine
Study (HINTS) trial assessed three telephone-based interventions in a four-arm design,
consisting of: 1) nurse-administered, behavioral management intervention; 2) nurse-
administered, physician-directed medication management intervention; 3) combined
behavioral management and medication management intervention; and 4) usual care [32].
Approximately 593 participants with poor BP control over the last 12 months were recruited
from primary care clinics associated with the Durham, North Carolina VA Medical Center.
The behavioral intervention consisted of 12–14 minute telephone calls, reinforced with
mailed hand-outs, addressing hypertension knowledge and evidence-based
recommendations regarding hypertension-related behaviors, including salt intake, weight,
stress reduction, smoking cessation, and alcohol use. When certain medication-related
triggers were activated, the nurse notified the study physician and provided a medication
recommended change. The physician made suggestions and medication adjustments as
indicated. The nurse subsequently communicated recommendations to patients and followed
up with the patient three weeks later. Outcome measures were assessed at 6-month intervals
over 18 months. Both the behavioral management and medication management alone
showed nearly 13% improvements at 12 months. These improvements were not sustained at
18 months. Improvements were greater for patients with poor baseline BP measures. For
these patients, BP in the combined intervention group decreased 14.8-mmHg [32]. The
authors suggest that identifying patients most likely to benefit from resource intensive
programs may be prudent [32]. The authors concluded overall and subgroup samples,
average intervention costs were similar in the 3 study arms, and at 18 months, there were no
statistically significant differences in direct VA medical costs or total VA costs between
treatment arms and usual care.
A recent study conducted by Magid and colleagues randomized 388 hypertensive patients to
usual care or a multimodal intervention which included patient education, home BP
monitoring, home BP reporting to interactive voice response system, and telephone-based
counseling by clinical pharmacist for BP management [28]. A physician initiated and titrated
antihypertensive medications with oversight from the study pharmacist. Patients with
elevated BP for two out of their most previous three BP measurements were enrolled from
three healthcare systems located in Denver, Colorado including integrated healthcare
systems. On average, patients were taking two anti-hypertensive medications, approximately
half had diabetes or chronic kidney disease, and between 11 and 13% were current smokers.
Baseline BP measurements were higher in the intervention groups than the usual care group.
At six-months BP reductions were greater for the intervention compared to the usual care
group (−13.1 vs. −7.1-mmHg, for systolic; −6.5 vs. −4.2-mmHg, for diastolic) [28].
Medication adherence rates were similar between the groups, but participants in the
intervention arm had greater therapy intensification (increase in medication dose or
additional medications added). Although it is unclear which aspects of the intervention were
most effective, this study suggests that a multimodal intervention improves BP control more
than usual care alone [28].
These studies suggest that multidisciplinary teams, involving nursing and pharmacy
professionals, can facilitate patient self-management via home-based telemonitoring for
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successful BP reduction and control. As home-based telemonitoring gains traction as a
routine part of primary care delivery, the evolving role of technology must be considered in
order to successfully reach, engage, and communicate with patients to facilitate hypertension
self-management and home-based telemonitoring.
The Evolving Role of Technology
Technology, both for BP monitoring and patient communication, is rapidly evolving. As a
result, novel approaches to home-based BP telemonitoring will advance. The interventions
that we highlight primarily use telephones. Many patients today use mobile phones, often
‘smart’ phones with Internet capabilities. In addition to the traditionally used telephone call
approach, interventions may now include as delivery mechanisms short message service,
also known as text messaging [12], e-mail, or smart phone and tablet enabled software
applications or ‘apps’. Logan and colleagues found in a RCT that self-care messages
delivered via a smartphone immediately after a home-based BP reading, improved blood
pressure control in the intervention group by −9.1 mmHg [45]. In addition, 51% of the
intervention subjects achieved a target of <130/80 mmHg compared with 31% of control
subjects.
Additional technological mediums include telehealth kiosks to facilitate “home-based”
telemonitoring in settings such as senior centers and community pharmacies [46, 47], web-
based [48, 49], and e-mail [50]. A recent web-based 3-arm RCT conducted in an integrated
health system randomly assigned patients to usual care, home BP monitoring and web site
training only, or home BP monitoring and Web site training plus online pharmacist
management. The study found that adding web-based pharmacist care to home BP
monitoring and web training significantly increased the percentage of patients with
controlled BP [48, 49]. Another study using e-mail effectively reduced salt intake with the
objective of improving BP. During this study, participants were sent 10 emails over a 4-
week period informing them about salt contact of foods, methods for salt reduction and
encouraged a salt-reduced diet. Patients were also instructed to self-report their BP via a
home monitor [50]. Lastly, online social media is another evolving forum for potential
interventions [51]. Patients increasingly expect to be able to communicate with their
providers via email and web-based messaging and interventions may naturally stem from
this interaction [52, 53]. However, research leveraging online social media and hypertension
self-management is still in its infancy.
These novel approaches are promising, and may increase access to patients living in rural
areas. Future studies must consider the evolving technological landscape, their patient
population, clinical goals, and how to best capitalize on the wide variety of available
technological resources to promote behavior change [54]. Nevertheless, caution must also be
exercised to ensure equal access to care. Patients who are of older age, lower socioeconomic
status, or with lower education levels may be less willing to participate in technology-
intensive interventions [55].
Limitations of Previous Studies and Gaps in Knowledge
We emphasize several key studies from a body of literature showing that home-based BP
telemonitoring interventions are helpful tools for promoting BP control.[56] Despite the
breadth of work that has been done, there remain several gaps in our understanding of the
role and effectiveness of home-based telemonitoring in improving BP control. Featured
below are four key gaps in existing literature:
• Length of Outcome Measure: For most patients, BP control is a life-long endeavor,
yet most interventions had relatively short durations for outcome measures (e.g., 12
months or less). A minority of studies looked at longer-term outcomes, spanning to
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24 months [32, 57]. The long-term effectiveness and clinical benefit of
interventions must be evaluated in order to understand whether improvements in
BP are sustained over time. Moreover, future work could examine “booster”
interventions to facilitate longer-term BP control.
• Sustainability: The interventions discussed were part of a specific research
program. At the conclusion of a research intervention, little is reported about how
effective interventions are translated into clinical practice. A focus on
implementation beyond the initial study is important. This is particularly critical as
many healthcare organizations transition to a patient-centered medical home model.
• Intervention Components: Most interventions are multimodal, involving many
components working in concert to effective BP control. To inform a better
understanding of what works well, authors should report detailed information about
the logistics of intervention implementation. For example, our understanding is
limited about the optimal frequency of BP monitoring and reporting, the ideal
degree of intensity of interventionist contact, and median telephone contact time.
This information is central to understanding intervention implementation,
sustainability, and cost.
• Cost: While there have been several cost-effectiveness analyses of home-based BP
telemonitoring interventions [13–17], they are often based on limited data. Because
of sparse information about long-term BP control and healthcare utilization, the
relative costs and benefits must be better defined. This is particularly true for the
type of interventionist where costs may vary significantly. More comprehensive
analyses are needed to determine whether these interventions produce a positive
return on the initial investment.
CONCLUSION
Managing hypertension has been a significant health need for over a decade [2]. The climate
of healthcare and availability of technology are evolving, and approaches to treating
hypertension must evolve in parallel. Primary care providers are increasingly in short
supply, the severity of that shortage is expected to continue [58], and there is a growing
emphasis on reducing healthcare costs. Thus, the use of clinicians such as nurses and
pharmacists will be instrumental in the delivery of effective, cost-conscious care. As the
healthcare climate shifts to a Patient Centered Medical Home model [5], involving
information technology and shared communication with the ultimate goal of truly patient-
centric care, much patient-centered care occurs outside of a traditional office-based care
setting. Home-based telemonitoring of chronic diseases, such as hypertension, fulfills a
critical role in this framework.
Home-based BP telemonitoring places the emphasis on patient involvement. It equips
patients with the knowledge, skills, and technology needed to manage their care. When
supplemented with nurse, nurse practitioner, or clinical pharmacist- mediated support,
patients can be guided to successfully achieve BP control while avoiding unnecessary office
visits. This eases the burden on primary care providers, empowers the patient, and is more
convenient for patients.
Despite the utility of home-based telemonitoring for BP control, more evidence is needed to
support the extent of its effectiveness. Specifically, more evidence is needed regarding the
cost effectiveness, the long-term impact of home-based BP monitoring, and the optimal use
of emerging technologies on clinical outcomes. Home-based BP telemonitoring
interventions must take advantage of rapidly advancing technology, both for communication
and BP monitoring, while taking into account the needs and preferences of the patient
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population served. At its core, home-based BP telemonitoring facilitates patient participation
in their own chronic disease management, placing patients at the center of care. Such
interventions will become increasingly important as the climate and structure of healthcare
continue evolving.
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